Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant

Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant

Mycophenolate mofetil (MMF) is an immunosuppressive agent, the gastrointestinal side effects of which include abdominal pain, diarrhoea, and vomiting. MMF may also cause symptomatic colitis, although it is a rare condition. We present herein the case of a boy with chronic kidney disease, lasting sin...

Full description

Bibliographic Details
Main Authors:	Natalia Oleksik, Monika Głowinkowska, Maria Szczepańska, Katarzyna Bąk-Drabik, Wioletta Jarmużek
Format:	Article
Language:	English
Published:	Termedia Publishing House 2022-10-01
Series:	Pediatria Polska
Subjects:	children mycophenolate mofetil kidney transplant colitis
Online Access:	https://www.termedia.pl/Mycophenolate-mofetil-related-colitis-in-a-paediatric-patient-after-kidney-transplant,127,47965,1,1.html

Similar Items

Mycophenolate Mofetil-Induced Segmental Colitis Mimicking Ischemic Colitis
by: Kevin Johal, et al.
Published: (2014-03-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Acute pancreatitis induced by mycophenolate mofetil in a kidney transplant patient
by: Einollahi Behzad, et al.
Published: (2015-04-01)

Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review
by: Alice Tung Wan Song, et al.

Effect of conversion from azathioprine to mycophenolate mofetil on renal function in stable kidney transplant recipients
by: Mehmet Usta, et al.
Published: (2019-10-01)

Duodenal villous atrophy caused by Mycophenolate Mofetil in patients with solid organ transplantation: case report
by: Giuston Mendoza-Chuctaya, et al.
Published: (2016-03-01)

Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium
by: Kina Jeon, et al.
Published: (2022-08-01)

Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
by: Jun Zhang, et al.
Published: (2018-08-01)

Mycophenolate Induced Colitis: One-year Post-kidney Transplantation
by: Waleed Al Saadi, et al.
Published: (2023-03-01)

Mycophenolate Mofetil-Induced Colitis with Graft Versus Host Disease-Like Features in a Renal Transplant Recipient: Case Report and Literature Review
by: Joana Gameiro, et al.
Published: (2018-07-01)

Successful Late Conversion to Mycophenolate Mofetil and Prednisone Immunosuppression Therapy in a Renal Transplant Recipient
by: Iqbal A, et al.
Published: (2000-01-01)

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
by: Seung Woon Park, et al.
Published: (2016-06-01)

Mycophenolate mofetil-induced colitis with graft versus host disease-like features in a liver transplant recipient
by: Sushma Patra, et al.
Published: (2012-01-01)

Mycophenolate mofetil in liver transplant patients with calcineurin-inhibitor-induced renal impairment
by: Hin Hin Ko, et al.
Published: (2008-10-01)

Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis
by: David Dias-Polak, et al.
Published: (2019-01-01)

Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
by: Douglas A. Simonetto, et al.
Published: (2018-05-01)

Outcomes of Late Corticosteroid Withdrawal after Renal Transplantation in Patients Exposed to Tacrolimus and/or Mycophenolate Mofetil: Meta-Analysis of Randomized Controlled Trials
by: AK Ali, et al.
Published: (2011-10-01)

Pharmacokinetic study of mycophenolic acid in Iranian kidney transplant patients.
by: Kheirollah Gholami, et al.
Published: (2015-10-01)

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)

Management of erythema nodosum leprosum by mycophenolate mofetil
by: Banerjee Kalyan, et al.
Published: (2008-01-01)

Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study
by: Hanisch F, et al.
Published: (2009-08-01)

The association of mycophenolate mofetil and human herpes virus infection
by: Jenny Sung Won Yun, et al.
Published: (2020-01-01)

Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
by: Yichen Jia, et al.
Published: (2018-07-01)

Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis: report of two cases and literature review
by: Ilse Andrea Moreno-Arquieta, et al.
Published: (2022-04-01)

Mycophenolate Mofetil;A Review of Indications and Use in a Large Tertiary Hospital
by: Nimeshan Geevasinga, et al.
Published: (2005-12-01)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
by: Heng-Yi Chiang, et al.
Published: (2023-07-01)

Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis
by: Niyaz Mostafa, et al.
Published: (2022-01-01)

Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2020-11-01)

Mycophenolate mofetil in giant cell arteritis
by: Anne Pankow, et al.
Published: (2023-11-01)

Graft-versus-Host Disease-Like Pattern in Mycophenolate Mofetil Related Colon Mucosal Injury: Role of FISH in Establishing the Diagnosis
by: Kathryn C. Behling, et al.
Published: (2009-12-01)

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation
by: Yinyi Wei, et al.
Published: (2022-10-01)

Mycophenolate mofetil in the treatment of non-renal manifestations of systemic lupus erythematosus: recent insights
by: Ali SAHIN
Published: (2010-05-01)

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies
by: C Bandelier
Published: (2009-01-01)

Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
by: Minoo Moghimi, et al.
Published: (2021-12-01)

Conversion to Combined Therapy with Sirolimus and Mycophenolate Mofetil Improved Renal Function in Stable Renal Transplant Recipients
by: Meng-Kun Tsai, et al.
Published: (2007-05-01)

Pharmacokinetics of mycophenolic acid and its effect on CD4+ and CD8+ T cells after oral administration of mycophenolate mofetil to healthy cats
by: Jennifer E. Slovak, et al.
Published: (2019-09-01)

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
by: Domenico Paolo Emanuele Margiotta, et al.
Published: (2018-03-01)

Simultaneous Spectrophotometric Determination of Mycophenolate Mofetil and Its Active Metabolite in Human Plasma Using Chemometrics Methods
by: Tayyebeh Madrakian, et al.
Published: (2015-06-01)

Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy
by: Luo Lei, et al.
Published: (2012-07-01)

Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial
by: Fatemeh Hayati, et al.
Published: (2019-04-01)